Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Design, Synthesis, and Biological Evaluation of a Novel Photocaged PI3K Inhibitor toward Precise Cancer Treatment
Kehui Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Photoswitchable CAR-T Cell Function In Vitro and In Vivo via a Cleavable Mediator
Bo Zhang et al.
CELL CHEMICAL BIOLOGY (2021)
Immunoproteasome Inhibitor-Doxorubicin Conjugates Target Multiple Myeloma Cells and Release Doxorubicin upon Low-Dose Photon Irradiation
Elmer Maurits et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Controlled Inhibition of Apoptosis by Photoactivatable Caspase Inhibitors
Suravi Chakrabarty et al.
CELL CHEMICAL BIOLOGY (2020)
Photo-Uncaging of a Microtubule-Targeted Rigidin Analogue in Hypoxic Cancer Cells and in a Xenograft Mouse Model
Vincent H. S. van Rixel et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
A Smart Europium-Ruthenium Complex as Anticancer Prodrug: Controllable Drug Release and Real-Time Monitoring under Different Light Excitations
Hongguang Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light
Mandi Karimi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Photodynamic therapy and pain: A systematic review
Jennifer Maria Ang et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2017)
N-(3-Ethynyl-2,4-difluorophenyl)sulfonamide Derivatives as Selective Raf Inhibitors
Yingjun Li et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluation
Piotr Rutkowski et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Identification and Optimization of New Dual Inhibitors of B-Raf and Epidermal Growth Factor Receptor Kinases for Overcoming Resistance against Vemurafenib
Huimin Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
Petr Klan et al.
CHEMICAL REVIEWS (2013)
Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors
Tara R. Rheault et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)